Dibenzazepine Attenuates Against Cisplatin-Induced Nephrotoxicity in Rats: Involvement of NOTCH Pathway
Cisplatin is one of the standard anti-cancer agents that are used to treat variety of solid tumors. Nevertheless, due to the accumulation of cisplatin in the renal epithelial cells, nephrotoxicity was found to be the main side effect that limits its clinical use. The current study was conducted to a...
Saved in:
Main Authors: | Rana H. Abd El-Rhman (Author), Reem N. El-Naga (Author), Amany M. Gad (Author), Mariane G. Tadros (Author), Sherifa K. Hassaneen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update
by: Pía Loren, et al.
Published: (2021) -
The effect of daily intraperitoneal injection of Deferoxamine in an acute model of Cisplatin induced nephrotoxicity
by: Mohamed M Elmazar, et al.
Published: (2020) -
Prevention of cisplatin nephrotoxicity
by: Hayati Fatemeh, et al.
Published: (2016) -
Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner
by: Bojana Simovic Markovic, et al.
Published: (2017) -
Therapeutic Effects of the Combination of Alpha-Lipoic Acid (ALA) and Coenzyme Q10 (CoQ10) on Cisplatin-Induced Nephrotoxicity
by: Eman Aly Khalifa, et al.
Published: (2020)